Hamisított Isten Növénytan abl protein Hírnök Ügyes pontosan
Cytoplasmic signalling by the câ•'Abl tyrosine kinase in normal and cancer cells
c‑Abl‑mediated tyrosine phosphorylation of DNA damage response proteins and implications in important cellular functions (Review)
Targeting BCR-ABL in Chronic Myelogenous Leukemia
Charting the molecular network of the drug target Bcr-Abl | PNAS
IJMS | Free Full-Text | c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair
Interplay between Kinase Domain Autophosphorylation and F-Actin Binding Domain in Regulating Imatinib Sensitivity and Nuclear Import of BCR-ABL | PLOS ONE
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D